Immunome
IMNM
#4281
Rank
ยฃ1.91 B
Marketcap
ยฃ16.93
Share price
2.65%
Change (1 day)
252.91%
Change (1 year)

Revenue for Immunome (IMNM)

Revenue in 2025 (TTM): ยฃ5.18 Million

According to Immunome's latest financial reports the company's current revenue (TTM ) is ยฃ5.23 Million. a decrease over the revenue in the year 2024 that were of ยฃ7.2 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immunome from 2020 to 2025

Annual revenue

Year Revenue Change
2025 ยฃ5.15 M-28.46%
2024 ยฃ7.2 M-34.52%
2023 ยฃ11 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA